Abstract
Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolf et al. further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.
Original language | English |
---|---|
Pages (from-to) | 909-911 |
Number of pages | 3 |
Journal | Kidney International |
Volume | 72 |
Issue number | 8 |
DOIs |
|
State | Published - Oct 2007 |